UBS AM’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,629
| Closed | -$8.57K | – | 2682 |
|
|
2017
Q4 | $8.57K | Hold |
1,629
| – | – | ﹤0.01% | 2508 |
|
|
2017
Q3 | $9.99K | Sell |
1,629
-116
| -7% | -$711 | ﹤0.01% | 2458 |
|
|
2017
Q2 | $12.6K | Hold |
1,745
| – | – | ﹤0.01% | 2443 |
|
|
2017
Q1 | $9.25K | Sell |
1,745
-334
| -16% | -$1.77K | ﹤0.01% | 2398 |
|
|
2016
Q4 | $15K | Buy |
+2,079
| New | +$15K | ﹤0.01% | 2367 |
|
|
2016
Q3 | – | Sell |
-61,267
| Closed | -$387K | – | 2609 |
|
|
2016
Q2 | $387K | Sell |
61,267
-45,418
| -43% | -$287K | ﹤0.01% | 2095 |
|
|
2016
Q1 | $589K | Sell |
106,685
-40,251
| -27% | -$222K | ﹤0.01% | 1848 |
|
|
2015
Q4 | $820K | Buy |
146,936
+52,128
| +55% | +$291K | ﹤0.01% | 1818 |
|
|
2015
Q3 | $802K | Buy |
94,808
+76,508
| +418% | +$647K | ﹤0.01% | 1816 |
|
|
2015
Q2 | $277K | Buy |
18,300
+4,300
| +31% | +$65.1K | ﹤0.01% | 2415 |
|
|
2015
Q1 | $224K | Buy |
14,000
+500
| +4% | +$8K | ﹤0.01% | 2432 |
|
|
2014
Q4 | $241K | Hold |
13,500
| – | – | ﹤0.01% | 2369 |
|
|
2014
Q3 | $136K | Buy |
+13,500
| New | +$136K | ﹤0.01% | 2460 |
|